Oral Session 3-7D Iatrogenic LPD

[OS3-7D-2] Clinicopathological analysis of LPD that developed in RA patients receiving calcineurin inhibitors

Yoshihiko Hoshida¹, Shiro Oshima², Yukihiko Saeki², Tomonori Kawasaki³, Syu Ichihara³, Atsushi Kaneko⁴, Masao Katayama⁵, Kazuo Kuraoka⁶, Michiko Kida⁷, Ikuo Saito⁸, Shigeto Tohma⁹, Mitsutoshi Kurosawa¹⁰, Hiroyuki Sugahara¹¹, Yasushi Hiramatsu¹², Hiroki Yabe¹³ (1.Pathology, Osaka Minami Medical Center, Kawachinagano, Japan, 2.Rheumatology, Osaka Minami Medical Center, Kawachinagano, Japan, 3.Pathology, Nagoya Medical Center, Nagoya, Japan, 4.Orthopedics, Nagoya Medical Center, Nagoya, Japan, 5.Rheumatology, Nagoya Medical Center, Nagoya, Japan, 6.Pathology, Kure Medical Center, Kure, Japan, 7.Hematology, Kure Medical Center, Kure, Japan, 8.Pathology, Sagamihara Hospital, Sagamihara, Japan, 9.Rheumatology, Tokyo Hospital, Tokyo, Japan, 10.Hematology, Hokkaido Cancer Center, Sapporo, Japan, 11.Hematology, Sumitomo Hospital, Osaka, Japan, 12.Hematology, HImeji Red Cross Hospital, Himeji, Japan, 13.Hematology, Ako Central Hospital, Ako, Japan)